Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers
Crossref DOI link: https://doi.org/10.1186/s13023-016-0444-9
Published Online: 2016-05-26
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Morel, T.
Aymé, S.
Cassiman, D.
Simoens, S.
Morgan, M.
Vandebroek, M.